S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:PETQ

PetIQ (PETQ) Stock Price, News & Analysis

$18.28
+0.84 (+4.82%)
(As of 03/28/2024 ET)
Today's Range
$17.51
$18.39
50-Day Range
$15.55
$19.04
52-Week Range
$10.78
$22.98
Volume
350,928 shs
Average Volume
298,184 shs
Market Capitalization
$537.98 million
P/E Ratio
304.72
Dividend Yield
N/A
Price Target
$29.00

PetIQ MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
58.6% Upside
$29.00 Price Target
Short Interest
Bearish
7.11% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.98mentions of PetIQ in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
29.79%
From $0.94 to $1.22 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.66 out of 5 stars

Medical Sector

490th out of 938 stocks

Drugs, Proprietaries, & Sundries Industry

6th out of 7 stocks

PETQ stock logo

About PetIQ Stock (NASDAQ:PETQ)

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.

PETQ Stock Price History

PETQ Stock News Headlines

PetIQ (NASDAQ:PETQ) Sees Strong Trading Volume
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
PetIQ (NASDAQ:PETQ) Shares Gap Up on Analyst Upgrade
PetIQ, Inc. (NASDAQ:PETQ) Q4 2023 Earnings Call Transcript
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Here's what to expect from PetIQ A's earnings
PetIQ: Q4 Earnings Snapshot
PETQ Jul 2024 17.500 put
PETQ Jan 2025 20.000 call
PetIQ Inc. Cl A
PETQ or ABT: Which Is the Better Value Stock Right Now?
Buy Rating for PetIQ Amid Growth Potential in Pet Health Sector
See More Headlines
Receive PETQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/28/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Current Symbol
NASDAQ:PETQ
Fax
N/A
Employees
1,933
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$29.00
High Stock Price Target
$30.00
Low Stock Price Target
$28.00
Potential Upside/Downside
+58.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$2.13 million
Pretax Margin
0.21%

Debt

Sales & Book Value

Annual Sales
$1.10 billion
Cash Flow
$2.76 per share
Book Value
$7.58 per share

Miscellaneous

Free Float
26,694,000
Market Cap
$537.98 million
Optionable
Optionable
Beta
1.65
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

PETQ Stock Analysis - Frequently Asked Questions

Should I buy or sell PetIQ stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PETQ shares.
View PETQ analyst ratings
or view top-rated stocks.

What is PetIQ's stock price target for 2024?

4 equities research analysts have issued 12 month price objectives for PetIQ's shares. Their PETQ share price targets range from $28.00 to $30.00. On average, they predict the company's share price to reach $29.00 in the next year. This suggests a possible upside of 58.6% from the stock's current price.
View analysts price targets for PETQ
or view top-rated stocks among Wall Street analysts.

How have PETQ shares performed in 2024?

PetIQ's stock was trading at $19.75 on January 1st, 2024. Since then, PETQ stock has decreased by 7.4% and is now trading at $18.28.
View the best growth stocks for 2024 here
.

When is PetIQ's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our PETQ earnings forecast
.

How were PetIQ's earnings last quarter?

PetIQ, Inc. (NASDAQ:PETQ) posted its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.38) by $0.22. The company had revenue of $219.93 million for the quarter, compared to analyst estimates of $189.70 million. PetIQ had a net margin of 0.19% and a trailing twelve-month return on equity of 11.72%.

What ETFs hold PetIQ's stock?

ETFs with the largest weight of PetIQ (NASDAQ:PETQ) stock in their portfolio include ProShares Pet Care ETF (PAWZ).Invesco Russell 2000 Dynamic Multifactor ETF (OMFS).

What guidance has PetIQ issued on next quarter's earnings?

PetIQ updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $290.0 million-$310.0 million.

What is Cord Christensen's approval rating as PetIQ's CEO?

10 employees have rated PetIQ Chief Executive Officer Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among the company's employees.

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

When did PetIQ IPO?

PetIQ (PETQ) raised $86 million in an IPO on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

Who are PetIQ's major shareholders?

PetIQ's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.30%), Vanguard Group Inc. (7.30%), Dimensional Fund Advisors LP (3.69%), Goldman Sachs Group Inc. (3.52%), Goldman Sachs Group Inc. (3.52%) and Boston Partners (3.40%). Insiders that own company stock include Allan Hall, John Newland, Mccord Christensen, Michael A Smith, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis and Zvi Glasman.
View institutional ownership trends
.

How do I buy shares of PetIQ?

Shares of PETQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PETQ) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners